Literature DB >> 19891889

European perspective of 2-person rule for biosafety level 4 laboratories.

Giuseppe Ippolito, Carla Nisii, Antonino Di Caro, David Brown, Robin Gopal, Roger Hewson, Graham Lloyd, Stephan Gunther, Markus Eickmann, Ali Mirazimi, Tuija Koivula, Marie-Claude Georges Courbot, Hervé Raoul, Maria R Capobianchi.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19891889      PMCID: PMC2857259          DOI: 10.3201/eid1511.091134

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Recently, the directors of Biosafety Level 4 (BSL-4) laboratories in the United States published their views of the requirement of having ≥2 persons present at all times while biological work is undertaken in a BSL-4 laboratory (). They concluded that safety and security would be better assured in some situations by video monitoring systems rather than by the presence of a fellow scientist. As members of the European Network of Biosafety Level-4 laboratories (Euronet-P4) who have developed guidelines in this area (–), we discussed the article during a recent network meeting. Biosafety and biosecurity are the major concerns for all involved in BSL-4 activities, and we support the authors’ initiative and broadly agree with their position. The consensus among European BSL-4 experts is that, in the interest of safety, standard practice should be for all laboratories to perform a risk assessment before any activity is undertaken. This preliminary assessment is the best way to determine procedures to be used, including whether 2 persons should work together as part of laboratory procedure. A 2-person rule is inappropriate simply because the best approach is not to have inflexible rules that are not objectively assessed according to laboratory-specific circumstances. Surveillance video monitoring and data storing have their place in protecting laboratory facilities from unauthorized access and theft of materials, but their effectiveness for ensuring proper handling of pathogens is quite limited. Finally, we agree with the authors that both biosafety and biosecurity must be founded on careful selection and monitoring of staff, without which even the most sophisticated of control systems would fail.
  3 in total

1.  Networking for infectious-disease emergencies in Europe.

Authors:  Giuseppe Ippolito; Carla Nisii; Maria R Capobianchi
Journal:  Nat Rev Microbiol       Date:  2008-07       Impact factor: 60.633

2.  Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers.

Authors:  James W LeDuc; Kevin Anderson; Marshall E Bloom; Ricardo Carrion; Heinz Feldmann; J Patrick Fitch; Joan B Geisbert; Thomas W Geisbert; Michael R Holbrook; Peter B Jahrling; Thomas G Ksiazek
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

Review 3.  The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats.

Authors:  C Nisii; C Castilletti; A Di Caro; M R Capobianchi; D Brown; G Lloyd; S Gunther; A Lundkvist; M Pletschette; G Ippolito
Journal:  Clin Microbiol Infect       Date:  2009-08       Impact factor: 8.067

  3 in total
  2 in total

1.  Biosecurity measures in 48 isolation facilities managing highly infectious diseases.

Authors:  Vincenzo Puro; Francesco M Fusco; Stefan Schilling; Gail Thomson; Giuseppina De Iaco; Philippe Brouqui; Helena C Maltezou; Barbara Bannister; René Gottschalk; Hans-Rheinhard Brodt; Giuseppe Ippolito
Journal:  Biosecur Bioterror       Date:  2012-05-09

2.  Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.

Authors:  Carla Nisii; Concetta Castilletti; Hervé Raoul; Roger Hewson; David Brown; Robin Gopal; Markus Eickmann; Stephan Gunther; Ali Mirazimi; Tuija Koivula; Heinz Feldmann; Antonino Di Caro; Maria R Capobianchi; Giuseppe Ippolito
Journal:  PLoS Pathog       Date:  2013-01-17       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.